Zynext Ventures

Feldan Therapeutics specializes in intracellular drug delivery using its patented Feldan Shuttle technology. This platform enables rapid, safe, and efficient transport of therapeutic agents into cells, with a focus on developing treatments for serious diseases such as skin and lung conditions.

Illexcor Therapeutics is a biopharmaceutical company focused on developing innovative oral therapies for sickle cell disease. It specializes in creating Hemoglobin S polymerization inhibitors, aiming to provide significant clinical benefits and improve the lives of patients living with this condition.

Neuro42 is a medical technology company focused on developing and commercializing portable magnetic resonance imaging and robotics solutions for diagnosis and image-guided interventions in neurology. The company designs compact MRI devices intended for point-of-care use to triage, screen, diagnose, and treat various brain conditions, including traumatic injury, epilepsy, and brain tumors. Its technology enables rapid imaging and supports robotic-assisted interventions outside traditional MRI suites, including stroke care, with the aim of expanding access to advanced neuroimaging and treatment in diverse clinical settings.